CLGN Key Statistics, Chart & Performance
The current stock price of CLGN is 1.42 USD. In the past month the price decreased by -31.39%. In the past year, price decreased by -57.14%.
CLGN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.49 | 409.06B | ||
| AMGN | AMGEN INC | 15.13 | 178.16B | ||
| GILD | GILEAD SCIENCES INC | 15.18 | 154.24B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 26.39 | 116.24B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.29 | 81.78B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 779.35 | 52.51B | ||
| INSM | INSMED INC | N/A | 37.57B | ||
| NTRA | NATERA INC | N/A | 32.11B | ||
| BIIB | BIOGEN INC | 10.57 | 25.96B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.98 | 21.56B | ||
| INCY | INCYTE CORP | 15.31 | 19.29B | ||
| EXAS | EXACT SCIENCES CORP | N/A | 19.27B |
Related stock screener links
About CLGN
Company Profile
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Company Info
COLLPLANT BIOTECHNOLOGIES LT
4 Oppenheimer Street, P.O. Box 4132
Rehovot 7670104 IL
CEO: Yehiel Tal
Employees: 57
Phone: 972732325600
COLLPLANT BIOTECHNOLOGIES LT / CLGN FAQ
What does CLGN do?
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Can you provide the latest stock price for COLLPLANT BIOTECHNOLOGIES LT?
The current stock price of CLGN is 1.42 USD. The price decreased by -7.19% in the last trading session.
What is the dividend status of COLLPLANT BIOTECHNOLOGIES LT?
CLGN does not pay a dividend.
What is the ChartMill rating of COLLPLANT BIOTECHNOLOGIES LT stock?
CLGN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the market expecting CLGN stock to perform?
8 analysts have analysed CLGN and the average price target is 11.73 USD. This implies a price increase of 726.06% is expected in the next year compared to the current price of 1.42.
Can you provide the growth outlook for COLLPLANT BIOTECHNOLOGIES LT?
The Revenue of COLLPLANT BIOTECHNOLOGIES LT (CLGN) is expected to grow by 422.12% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for COLLPLANT BIOTECHNOLOGIES LT?
COLLPLANT BIOTECHNOLOGIES LT (CLGN) has a market capitalization of 18.15M USD. This makes CLGN a Nano Cap stock.
CLGN Technical Analysis
CLGN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CLGN. The financial health of CLGN is average, but there are quite some concerns on its profitability.
CLGN Financial Highlights
Over the last trailing twelve months CLGN reported a non-GAAP Earnings per Share(EPS) of -1.02. The EPS increased by 25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -86.31% | ||
| ROE | -130.68% | ||
| Debt/Equity | 0 |
CLGN Forecast & Estimates
8 analysts have analysed CLGN and the average price target is 11.73 USD. This implies a price increase of 726.06% is expected in the next year compared to the current price of 1.42.
For the next year, analysts expect an EPS growth of 77.99% and a revenue growth 422.12% for CLGN